Literature DB >> 22687385

Clinical features and relapse rates after surgery in type 1 autoimmune pancreatitis differ from type 2: a study of 114 surgically treated European patients.

Sönke Detlefsen1, Giuseppe Zamboni, Luca Frulloni, Bernd Feyerabend, Felix Braun, Oke Gerke, Anna Melissa Schlitter, Irene Esposito, Günter Klöppel.   

Abstract

BACKGROUND: At the recent consensus conference on autoimmune pancreatitis (AIP) in Honolulu, we presented preliminary data from our study of surgically treated AIP patients. Our data strongly supported the separation of AIP into type 1 and type 2. Our study is based on a total of 114 surgically treated European AIP patients. Our aims were to elucidate serum IgG4 elevation, other organ involvement, relapse of disease, steroid treatment and diabetes after surgery in 114 surgically treated European AIP patients.
METHODS: 88 pancreaticoduodenectomies, 22 left-sided resections and 4 total pancreatectomies were examined. All cases were graded for granulocytic epithelial lesions, IgG4-positive cells, storiform fibrosis, phlebitis and eosinophilic granulocytes. Follow-up data were obtained from 102/114 patients, mean follow-up was 5.3 years.
RESULTS: Histologically, 63 (55.3%) of the 114 patients fulfilled the criteria of type 1 AIP, while 51 (44.7%) patients fulfilled the criteria of type 2 AIP. Type 1 AIP patients were older and more often males than type 2 AIP patients. Elevation of serum IgG4, involvement of extrapancreatic organs, disease relapse, systemic steroid treatment and diabetes after surgery were noted more often in type 1 AIP, while inflammatory bowel disease (IBD) was observed mainly in type 2 AIP.
CONCLUSIONS: Histological typing of AIP is clinically important because type 1 AIP is part of the IgG4-related disease and type 2 AIP is associated with IBD. Our data also show that relapse of disease and steroid treatment after surgery occur more frequently in type 1 than in type 2 AIP.
Copyright © 2012 IAP and EPC. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22687385     DOI: 10.1016/j.pan.2012.03.055

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  30 in total

1.  Potential role of Th17 cells in the pathogenesis of type 2 autoimmune pancreatitis.

Authors:  M Loos; F Lauffer; A M Schlitter; J Kleeff; H Friess; G Klöppel; I Esposito
Journal:  Virchows Arch       Date:  2015-10-01       Impact factor: 4.064

2.  Application of international consensus diagnostic criteria to an Italian series of autoimmune pancreatitis.

Authors:  Tsukasa Ikeura; Riccardo Manfredi; Giuseppe Zamboni; Riccardo Negrelli; Paola Capelli; Antonio Amodio; Anna Caliò; Giulia Colletta; Armando Gabbrielli; Luigi Benini; Kazuichi Okazaki; Italo Vantini; Luca Frulloni
Journal:  United European Gastroenterol J       Date:  2013-08       Impact factor: 4.623

Review 3.  [Histopathology of IgG4-related disease].

Authors:  S Detlefsen; G Klöppel
Journal:  Z Rheumatol       Date:  2016-09       Impact factor: 1.372

Review 4.  Diagnosis and Management of Autoimmune Pancreatitis.

Authors:  Phil A Hart; Somashekar G Krishna; Kazuichi Okazaki
Journal:  Curr Treat Options Gastroenterol       Date:  2017-12

Review 5.  [IgG4-related disease : Microscopic diagnosis and differential diagnosis].

Authors:  S Detlefsen
Journal:  Pathologe       Date:  2019-11       Impact factor: 1.011

6.  European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations.

Authors:  J-Matthias Löhr; Ulrich Beuers; Miroslav Vujasinovic; Domenico Alvaro; Jens Brøndum Frøkjær; Frank Buttgereit; Gabriele Capurso; Emma L Culver; Enrique de-Madaria; Emanuel Della-Torre; Sönke Detlefsen; Enrique Dominguez-Muñoz; Piotr Czubkowski; Nils Ewald; Luca Frulloni; Natalya Gubergrits; Deniz Guney Duman; Thilo Hackert; Julio Iglesias-Garcia; Nikolaos Kartalis; Andrea Laghi; Frank Lammert; Fredrik Lindgren; Alexey Okhlobystin; Grzegorz Oracz; Andrea Parniczky; Raffaella Maria Pozzi Mucelli; Vinciane Rebours; Jonas Rosendahl; Nicolas Schleinitz; Alexander Schneider; Eric Fh van Bommel; Caroline Sophie Verbeke; Marie Pierre Vullierme; Heiko Witt
Journal:  United European Gastroenterol J       Date:  2020-06-18       Impact factor: 4.623

7.  Surgery in Autoimmune Pancreatitis.

Authors:  Sara Nikolic; Poya Ghorbani; Raffaella Pozzi Mucelli; Sam Ghazi; Francisco Baldaque-Silva; Marco Del Chiaro; Ernesto Sparrelid; Caroline S Verbeke; J-Matthias Löhr; Miroslav Vujasinovic
Journal:  Dig Surg       Date:  2021-12-15       Impact factor: 2.588

8.  [Autoimmune pancreatitis--treatment and pitfalls in diagnostics].

Authors:  S Rasch; V Phillip; G Weirich; I Esposito; J Gaa; R M Schmid; H Algül
Journal:  Internist (Berl)       Date:  2014-10       Impact factor: 0.743

9.  Multicentric Italian survey on daily practice for autoimmune pancreatitis: Clinical data, diagnosis, treatment, and evolution toward pancreatic insufficiency.

Authors:  Luca Barresi; Matteo Tacelli; Stefano Francesco Crinò; Fabia Attili; Maria Chiara Petrone; Germana De Nucci; Silvia Carrara; Guido Manfredi; Gabriele Capurso; Claudio Giovanni De Angelis; Lucia Crocellà; Alberto Fantin; Maria Francesca Dore; Alessandra Tina Garribba; Ilaria Tarantino; Nicolò De Pretis; Danilo Pagliari; Gemma Rossi; Gianpiero Manes; Paoletta Preatoni; Ilenia Barbuscio; Fabio Tuzzolino; Mario Traina; Luca Frulloni; Guido Costamagna; Paolo Giorgio Arcidiacono; Elisabetta Buscarini; Raffaele Pezzilli
Journal:  United European Gastroenterol J       Date:  2020-05-12       Impact factor: 4.623

Review 10.  IgG4-related disease: with emphasis on the biopsy diagnosis of autoimmune pancreatitis and sclerosing cholangitis.

Authors:  Sönke Detlefsen; Günter Klöppel
Journal:  Virchows Arch       Date:  2017-12-01       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.